1. Home
  2. Stock quotes
  3. The GEO Group
  4. Financial Ratios
The GEO Group logo
The GEO Group GEO
$ 16.85 -1.98%

Quarterly report 2025-Q3
added 11-06-2025

report update icon

The GEO Group Financial Ratios 2011-2025 | GEO

Annual Financial Ratios The GEO Group

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 112.2 14.0 6.3 12.1 8.8 11.6 18.6 18.6 20.4 15.6 21.9 20.7 9.5 13.5

P/S

 1.5 0.6 0.5 0.4 0.4 0.8 1.2 1.2 1.4 1.2 1.9 1.6 0.5 0.7

EPS

 0.2 0.7 1.2 0.6 0.9 1.4 1.2 1.2 1.3 1.3 2.0 1.6 2.2 1.1

EV (Enterprise Value)

 3.51 B 1.41 B 995 M 426 M 715 M 5.22 B 5.87 B 5.66 B 5.74 B 4.62 B 5.06 B 4.19 B 2.75 B 2.23 B

EBITDA per Share

 3.32 3.92 4.27 3.52 3.04 3.62 3.25 3.1 3.43 3.1 3.05 2.63 4.33 3.44

EV/EBITDA

 0.8 9.8 10.8 13.8 14.0 14.1 12.4 14.3 13.9 8.3 10.3

PEG

 -229.01 2.89 0.85 9.32 35.16 0.74 -22.68 -2.07 3.22 -3.11 0.96 -0.77 7.05 -2.0

P/B

 1.0 0.4 0.3 0.2 0.2 1.9 2.6 2.3 3.1 2.2 3.0 2.3 0.7 0.8

P/CF

 14.8 5.4 3.8 3.3 2.3 8.8 34.2 11.7 -27.7 88.7 35.6 31.9 -21.0 29.5

ROE %

 2.39 8.31 14.75 7.94 12.39 16.73 13.95 12.20 15.25 13.85 13.76 11.24 7.68 6.23

ROA %

 0.88 2.90 4.57 1.71 2.53 3.86 3.42 3.46 3.97 3.98 4.79 3.98 2.58 2.62

ROCE %

 23.22 27.28 32.95 29.55 25.15 7.66 7.45 6.44 8.18 7.31 8.54 6.96 6.96 6.15

Current Ratio

 - - - - - 1.4 0.9 1.6 1.4 1.6 1.5 1.7 1.6 1.6

DSO

 57.7 61.0 60.0 58.9 61.6 65.1 72.2 65.8 97.2 62.2 58.1 60.1 66.3 79.2

DPO

 - - - - - 19.5 19.3 19.9 17.6 20.7 17.0 15.3 20.8 27.7

Operating Cycle

 57.7 61.0 60.0 58.9 61.6 65.1 72.2 65.8 97.2 62.2 58.1 60.1 66.3 79.2

Cash Conversion Cycle

 57.7 61.0 60.0 58.9 61.6 45.7 52.8 45.9 79.6 41.4 41.0 44.7 45.4 51.5

All numbers in USD currency

Quarterly Financial Ratios The GEO Group

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 1.26 0.21 0.14 - 0.19 -0.25 0.15 - 0.17 0.2 0.19 - 0.26 0.37 0.26 - 0.24 0.29 0.41 0.09 0.33 0.31 0.21 0.32 0.39 0.35 0.34 0.28 0.33 0.31 0.29 0.3 0.31 0.25 0.36 0.44 0.39 0.21 0.29 0.6 0.52 0.38 0.39 0.52 0.54 0.54 0.39 0.39 0.42 0.48 0.33 1.33 0.26 0.37 0.25 0.37 0.34 0.33 0.26

EBITDA per Share

 0.53 0.76 0.68 - 0.84 0.85 0.91 - 0.94 1.02 1.03 - 1.08 1.05 0.97 - 1.45 1.16 0.83 0.31 1.38 1.1 0.75 0.55 1.47 1.23 0.9 0.53 1.37 1.08 0.79 0.54 1.27 0.94 0.82 0.6 1.42 1.11 0.79 0.89 1.92 1.42 1.06 0.84 1.87 1.52 1.02 0.67 1.62 1.38 0.91 0.55 1.97 1.61 1.03 0.67 1.72 1.33 0.89

ROE %

 16.99 7.57 2.92 1.20 3.14 3.09 8.03 6.68 10.14 11.64 14.26 12.22 15.63 15.59 14.82 13.05 14.35 15.24 15.00 12.38 14.89 15.20 15.39 16.71 16.11 15.27 14.67 13.94 13.77 13.20 12.19 12.19 14.23 15.51 15.30 15.25 14.56 13.88 14.31 13.85 13.11 13.04 13.95 13.76 12.82 12.02 11.64 11.25 16.35 14.92 13.73 12.87 7.17 7.76 7.64 5.73 2.09 2.03 1.62

ROA %

 6.62 2.78 1.10 0.45 1.11 1.04 2.74 2.22 3.25 3.63 4.01 3.04 3.80 3.52 3.26 2.82 3.08 3.21 3.11 2.53 3.15 3.33 3.48 3.86 3.76 3.62 3.53 3.41 3.48 3.47 3.33 3.46 3.92 4.17 4.06 3.97 3.92 3.86 4.06 4.03 4.02 4.21 4.69 4.79 4.48 4.22 4.11 3.98 5.90 5.42 5.03 4.75 2.59 2.76 2.69 2.01 0.72 0.72 0.57

ROCE %

 18.69 22.28 23.33 18.60 25.25 25.62 26.86 21.87 30.70 32.89 34.28 25.71 32.98 31.42 29.88 21.61 25.77 25.59 25.34 24.51 26.99 27.74 28.79 30.14 29.59 28.45 26.74 25.44 24.88 23.42 21.53 20.70 22.14 24.32 26.54 27.24 26.89 25.72 24.25 23.42 22.71 22.50 23.03 22.45 21.21 19.54 18.74 18.12 17.19 17.74 17.77 17.61 18.11 17.77 17.07 16.92 4.59 4.35 3.73

DSO

 56.3 55.5 57.4 - 56.9 55.7 56.2 - 53.5 53.8 57.4 - 55.9 56.7 60.0 - 52.5 53.3 56.2 57.2 57.1 56.3 59.9 63.3 62.3 64.0 65.5 67.8 69.7 69.7 19106.3 62.5 26512.5 61.7 61.8 - 19201.6 59.3 60.0 - 21389.1 25499.4 62.2 - 53.6 59.5 60.3 - 60.2 59.9 60.2 - 61.0 52338.2 31865.1 - 93597.7 18094.1 -

Operating Cycle

 56.3 55.5 57.4 - 56.9 55.7 56.2 - 53.5 53.8 57.4 - 55.9 56.7 60.0 - 52.5 53.3 56.2 57.2 57.1 56.3 59.9 63.3 62.3 64.0 65.5 67.8 69.7 69.7 19106.3 62.5 26512.5 61.7 61.8 - 19201.6 59.3 60.0 - 21389.1 25499.4 62.2 - 53.6 59.5 60.3 - 60.2 59.9 60.2 - 61.0 52338.2 31865.1 - 93597.7 18094.1 -

Cash Conversion Cycle

 56.3 55.5 57.4 - 56.9 55.7 56.2 - 53.5 53.8 57.4 - 55.9 56.7 60.0 - 52.5 53.3 56.2 57.2 57.1 56.3 59.9 63.3 62.3 64.0 65.5 67.8 69.7 69.7 19106.3 62.5 26512.5 61.7 61.8 - 19201.6 59.3 60.0 - 21389.1 25499.4 62.2 - 53.6 59.5 60.3 - 60.2 59.9 60.2 - 61.0 52338.2 31865.1 - 93597.7 18094.1 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company The GEO Group, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Reit healthcare industry

Issuer Price % 24h Market Cap Country
LTC Properties LTC Properties
LTC
 		$ 34.76 1.13 % $ 1.52 B usaUSA
Healthpeak Properties Healthpeak Properties
PEAK
 		- 2.09 % $ 9.35 B usaUSA
Global Medical REIT Global Medical REIT
GMRE
 		$ 35.13 0.6 % $ 2.32 B usaUSA
Omega Healthcare Investors Omega Healthcare Investors
OHI
 		$ 43.85 0.27 % $ 11.3 B usaUSA
National Health Investors National Health Investors
NHI
 		$ 77.55 2.21 % $ 3.4 B usaUSA
Sabra Health Care REIT Sabra Health Care REIT
SBRA
 		$ 19.14 1.85 % $ 4.47 B usaUSA
Welltower Welltower
WELL
 		$ 186.39 0.77 % $ 112 B usaUSA
Ventas Ventas
VTR
 		$ 77.82 0.71 % $ 32 B usaUSA